Sentence examples for based on the mcc from inspiring English sources

One value for the pooled predictions (pooling true positives, false positives, true negatives, and false negatives) was calculated, and secondly an average MCC was calculated based on the MCC values per protein.

Tables 2 and 3 show that MFDp consistently outperforms all methods based on the MCC index.

The consensus predictor is significantly better than all the Scansite predictors and ELM, based on the MCC scores obtained for the BLIND dataset (P < 0.05).

The PPCpred outperforms the existing solutions in both the binary prediction (based on the MCC and ACC scores) and the real-valued propensities (based on the AUC values).

In spite of using training chains with ≤25% similarity to the test sequences, our method consistently and significantly outperforms the other methods based on the MCC index.

Based on the MCC values, the most accurate prediction (0.89) for a secretome includes secreted entries predicted by at least three out of four predictors with a specificity of 96.0% and a sensitivity of 93.5% (Table 1b).

Based on the discussions above, MCC is more accurate when the density of constraints in the network is more uniform.

Furthermore, based on the maximum correlation coefficient (MCC) criterion, the optimized Laplace wavelet base is determined, which is then designed as a health indicator to detect the crack fault.

Based on the histological similarities between MCC and pulmonary NEC, including SCLC and large-cell NEC (LCNEC), the possible association between MCPyV and pulmonary NEC has been studied.

The course learning objectives were based on the Medical Council of Canada's (MCC) Objectives for the Qualifying Examination Part I, which are based on the Royal College of Physicians and Surgeons of Canada's CanMEDS (Canadian Medical Educations Directives for Specialists) framework for physicians' roles [ 45].

In our main analyses, we identified individuals as having mCC based on the receipt of at least one of four antineoplastic agents - irinotecan, bevacizumab, cetuximab and panitumumab - that are FDA-approved and recommended by available guidelines only for the metastatic disease setting.